Skip to content

Author

Xuan Liu

We have 2 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Microbiota–innate immune crosstalk drives atherosclerosis: mechanisms, disease progression, and emerging therapeutic strategies

The microbiota–innate immune axis provides a novel conceptual framework for understanding atherosclerosis pathogenesis and represents a promising target for future disease prevention, risk stratification, and precision therapeutics.

Yong-Ang Li, Jin-Heng Zhu, Mingkui Huang et al. · 1 citation
Open access Sep 2026

Preclinical evaluation of AL-001, a gene therapy for wet age-related macular degeneration

Suprachoroidal administration of AL-001 is well tolerated and provides durable, targeted aflibercept expression with pronounced antiangiogenic efficacy, and these results support AL-001 as a promising, long-acting therapeutic candidate for wAMD.

Xuan Liu, Hai-Yan Liu, Lei Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.